ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

75
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
14 Oct 2020 16:08

Simcere Pharmaceutical IPO: Valuation Insights

We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range

Logo
471 Views
Share
bullishMSCI ACWI Index
24 Jul 2020 08:15

U.S. Dollar Breakdown: Bullish For Ex-U.S. Equities

Global indexes including the MSCI ACWI and ACWI ex-US are following in the MSCI EM index’s footsteps by breaking to new highs. This is bullish and...

Logo
439 Views
Share
bearishMSCI ACWI Index
23 Apr 2020 20:58

Global Equity Rally Losing Upside Momentum

The global rally appears to be losing steam as the bearish rising wedge patterns we highlighted last week in the MSCI ACWI, ACWI ex-US, EM, and...

Logo
416 Views
Share
18 Mar 2020 12:02

Trade Idea: Short Henlius Upon Lock-Up Expiry & 2H Results, HLX01 Likely Underperformed

Shanghai Henlius Biotech (2696 HK) IPO lock-up will expire on 25th of March, six months post its listing. The stock has been underwater since...

Logo
358 Views
Share
25 Sep 2019 08:13

Henlius (复宏汉霖) Post-IPO Trading: Weak Demands Ahead of Debut, Downside Remains

Shanghai Henlius' IPO was priced at the low end and started trading today. We have highlighted in our earlier note that the IPO is over-valued with...

Logo
515 Views
Share
x